Calum Harvey

579 total citations
18 papers, 277 citations indexed

About

Calum Harvey is a scholar working on Genetics, Neurology and Molecular Biology. According to data from OpenAlex, Calum Harvey has authored 18 papers receiving a total of 277 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Genetics, 6 papers in Neurology and 4 papers in Molecular Biology. Recurrent topics in Calum Harvey's work include Amyotrophic Lateral Sclerosis Research (6 papers), Neurogenetic and Muscular Disorders Research (5 papers) and Neurological diseases and metabolism (2 papers). Calum Harvey is often cited by papers focused on Amyotrophic Lateral Sclerosis Research (6 papers), Neurogenetic and Muscular Disorders Research (5 papers) and Neurological diseases and metabolism (2 papers). Calum Harvey collaborates with scholars based in United Kingdom, United States and Netherlands. Calum Harvey's co-authors include Johnathan Cooper‐Knock, Sai Zhang, Tobias Moll, Thomas Julian, M Snyder, Pamela J. Shaw, Mark R. Hempton, Adrian Barry, John D. Marshall and Yann C. Klimentidis and has published in prestigious journals such as The Lancet, Brain and Archives of Disease in Childhood.

In The Last Decade

Calum Harvey

17 papers receiving 266 citations

Peers

Calum Harvey

NEURO

GENET

Zhuo Zhang Singapore

F. Lelong France

John Blackwell United States

T.C. Booth United Kingdom

Jennifer Becker United States

Xiaoguang Tong China

Anna Aureli Italy

Vimal Kumar India

Michael Grunert Germany

Zhuo Zhang Singapore

Calum Harvey

39 ×0.4

NEURO

42 ×0.6

GENET

48 ×0.9

5 ×0.1

8 ×0.2

Citations per year, relative to Calum Harvey Calum Harvey (= 1×) peers Zhuo Zhang

Countries citing papers authored by Calum Harvey

Since Specialization

Citations

This map shows the geographic impact of Calum Harvey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Calum Harvey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Calum Harvey more than expected).

Fields of papers citing papers by Calum Harvey

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Calum Harvey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Calum Harvey. The network helps show where Calum Harvey may publish in the future.

Co-authorship network of co-authors of Calum Harvey

This figure shows the co-authorship network connecting the top 25 collaborators of Calum Harvey. A scholar is included among the top collaborators of Calum Harvey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Calum Harvey. Calum Harvey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Harvey, Calum, Aga Nowak, Sai Zhang, et al.. (2025). Evaluation of a biomarker for amyotrophic lateral sclerosis derived from a hypomethylated DNA signature of human motor neurons. BMC Medical Genomics. 18(1). 10–10.

Moll, Tobias, Valerie Odon, Calum Harvey, et al.. (2022). Low expression of EXOSC2 protects against clinical COVID-19 and impedes SARS-CoV-2 replication. Life Science Alliance. 6(1). e202201449–e202201449. 3 indexed citations

Zhang, Sai, Johnathan Cooper‐Knock, Annika K. Weimer, et al.. (2022). Multiomic analysis reveals cell-type-specific molecular determinants of COVID-19 severity. Cell Systems. 13(8). 598–614.e6. 14 indexed citations

Moll, Tobias, Alexander McGown, Thomas Julian, et al.. (2022). Unbiased metabolome screen leads to personalized medicine strategy for amyotrophic lateral sclerosis. Brain Communications. 4(2). fcac069–fcac069. 11 indexed citations

Julian, Thomas, Adrian Barry, Tobias Moll, et al.. (2021). Physical exercise is a risk factor for amyotrophic lateral sclerosis: Convergent evidence from Mendelian randomisation, transcriptomics and risk genotypes. EBioMedicine. 68. 103397–103397. 84 indexed citations

Julian, Thomas, Tobias Moll, Calum Harvey, et al.. (2021). A review of Mendelian randomization in amyotrophic lateral sclerosis. Brain. 145(3). 832–842. 50 indexed citations

Cooper‐Knock, Johnathan, Calum Harvey, Sai Zhang, et al.. (2021). Advances in the genetic classification of amyotrophic lateral sclerosis. Current Opinion in Neurology. 34(5). 756–764. 15 indexed citations

Zhang, Sai, Johnathan Cooper‐Knock, Annika K. Weimer, et al.. (2020). Genome-Wide Identification of the Genetic Basis of Amyotrophic Lateral Sclerosis. SSRN Electronic Journal. 1 indexed citations

Harvey, Calum, et al.. (2010). Regional Reservoir Quality of a Tight Gas Play: the Ordovician Sarah Formation in the Rub' Al Khali Basin of Southern Saudi Arabia. Proceedings. 5 indexed citations

10.

LeReun, C, et al.. (2010). PIN9 EFFICACY AND SAFETY OF RALTEGRAVIR IN TREATMENT NAIVE HIV + PATIENTS:A MIXED TREATMENT COMPARISON APPROACH. Value in Health. 13(7). A548–A548. 1 indexed citations

11.

Jackson, Debra, et al.. (2010). PIN20 A MODELED ECONOMIC EVALUATION OF RALTEGRAVIR COMPARED TO STANDARD PRACTICE IN AUSTRALIA FOR TREATMENT NAÏVE PATIENTS WITH HIV. Value in Health. 13(7). A550–A550. 4 indexed citations

12.

McSporran, K.D., et al.. (2009). Protozoal Hepatitis Associated with Immunosuppressive Therapy in a Dog. Journal of Veterinary Internal Medicine. 23(2). 366–368. 12 indexed citations

13.

Hempton, Mark R., et al.. (2005). Turbidite reservoirs of the Sele Formation, Central North Sea: geological challenges for improving production. Geological Society London Petroleum Geology Conference series. 6(1). 449–459. 45 indexed citations

14.

Chakrabarti, Suparno, Richard Lovell, Calum Harvey, et al.. (2004). A randomised study comparing peripheral blood progenitor mobilisation using intermediate-dose cyclophosphamide plus lenograstim with lenograstim alone. Bone Marrow Transplantation. 34(5). 399–403. 13 indexed citations

15.

Holt, David E. & Calum Harvey. (1994). Glottic stenosis secondary to vocal fold resection: results of scar removal and corticosteroid treatment in nine dogs. Journal of the American Animal Hospital Association. 6 indexed citations

16.

Harvey, Calum, Jonathan S. Dixon, & H. A. Bird. (1983). Serum IgA concentration and hepatotoxicity in rheumatoid arthritis treated with azathioprine.. BMJ. 287(6391). 534–534. 8 indexed citations

17.

Cusworth, D. C., Victor Dubowitz, & Calum Harvey. (1966). HYPERMETHIONINÆMIA IN ACUTE TYROSINOSIS. The Lancet. 287(7437). 598–599. 3 indexed citations

18.

Beasley, D. Michael G., J. T. Chesterman, & Calum Harvey. (1954). Pulmonary Artery Aneurysm in a Young Child. Archives of Disease in Childhood. 29(146). 346–348. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact